Current Issues in Pharmacy and Medical Sciences

Scope & Guideline

Exploring the frontiers of pharmacy and medical science.

Introduction

Explore the comprehensive scope of Current Issues in Pharmacy and Medical Sciences through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Current Issues in Pharmacy and Medical Sciences in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2084-980x
PublisherSCIENDO
Support Open AccessYes
CountryPoland
TypeJournal
Convergefrom 2012 to 2024
AbbreviationCURR ISS PHARM MED S / Curr. Iss. Pharm. Med. Sci.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBOGUMILA ZUGA 32A, WARSAW, MAZOVIA 01-811, POLAND

Aims and Scopes

The journal 'Current Issues in Pharmacy and Medical Sciences' focuses on a diverse range of topics at the intersection of pharmacy and medical research. It aims to provide a platform for innovative research that contributes to the understanding and improvement of health outcomes through the application of pharmaceutical sciences and medical knowledge.
  1. Pharmaceutical Research and Development:
    The journal publishes studies on the formulation, development, and evaluation of pharmaceutical products, including drug delivery systems, nanotechnology, and herbal medicines.
  2. Clinical and Therapeutic Studies:
    It emphasizes clinical trials, therapeutic efficacy, and safety assessment of drugs, providing insights into treatment protocols and patient care.
  3. Molecular and Cellular Biology:
    Research on the molecular mechanisms underlying diseases, including cancer and metabolic disorders, is a core focus, reflecting the journal's commitment to advancing biomedical sciences.
  4. Public Health and Epidemiology:
    The journal addresses public health issues, risk factors for diseases, and the impact of healthcare systems, particularly in specific populations and geographic regions.
  5. Natural Products and Ethnopharmacology:
    There is a consistent focus on the exploration of natural products, their pharmacological properties, and traditional medicine, emphasizing their relevance in modern therapeutic contexts.
The journal has adapted to emerging trends in healthcare and scientific research, with several themes gaining traction in recent years. This reflects a dynamic response to global health challenges and advancements in medical science.
  1. Integrative and Complementary Medicine:
    There is a growing interest in studies that explore the synergistic effects of herbal and dietary supplements in conjunction with conventional therapies, reflecting a holistic approach to patient care.
  2. Impact of Environmental Factors on Health:
    Research examining the influence of environmental exposures and lifestyle factors on health outcomes has increased, highlighting the importance of public health in the context of global changes.
  3. Precision Medicine and Biomarkers:
    Emerging research on predictive biomarkers and personalized treatment strategies is on the rise, indicating a shift towards tailored healthcare solutions.
  4. Microbiome Studies:
    Studies focusing on the gut microbiome and its impact on various health conditions are trending, reflecting increased awareness of its role in overall health and disease management.
  5. COVID-19 Related Research:
    The journal has seen a surge in publications related to COVID-19, including vaccine development, therapeutic interventions, and the long-term effects of the pandemic on health systems.

Declining or Waning

While 'Current Issues in Pharmacy and Medical Sciences' has seen a robust publication record, certain themes appear to be declining in prominence. This may reflect evolving research priorities or a shift in the scientific community's focus.
  1. Traditional Pharmacotherapy:
    Research on conventional drug therapies without innovative approaches has decreased, possibly due to a shift towards personalized medicine and novel therapeutic strategies.
  2. Basic Laboratory Studies:
    There is a noticeable decline in studies focused solely on basic laboratory experiments without direct clinical relevance, indicating a preference for translational research.
  3. General Health Education:
    Papers centered on basic health education are appearing less frequently, as the journal pivots towards more complex and research-driven topics that require clinical insights.

Similar Journals

JOURNAL OF PHARMACY AND PHARMACOLOGY

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

Pharmacy Practice-Granada

Transforming healthcare with cutting-edge pharmaceutical insights.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

Journal of Reports in Pharmaceutical Sciences

Bridging Research and Practice in Pharmaceutical Sciences.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2322-1232Frequency: 2 issues/year

Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.

Annales Pharmaceutiques Francaises

Cultivating Insights in Pharmaceutical Science for Future Generations
Publisher: MASSON EDITEURISSN: 0003-4509Frequency: 6 issues/year

Annales Pharmaceutiques Francaises, an esteemed journal published by MASSON EDITEUR, serves as a pivotal platform in the field of Pharmaceutical Science and Pharmacology. Established in 1945 and continuing through 2024, this journal showcases significant contributions to the advancement of pharmaceutical sciences, bridging the gap between research, development, and practical applications. Although it currently does not offer open access, its established reputation and Q3 ranking in both Pharmaceutical Science and Pharmacology highlight its role in disseminating impactful studies. With an ISSN of 0003-4509, the journal is indexed in Scopus, boasting a respectable percentile ranking for both domains, and remains a vital resource for researchers, professionals, and students dedicated to exploring the latest advancements in the pharmaceutical field. Based in France, at 21 Street Camille Desmoulins, Issy, 92789 Moulinais Cedex 9, it aims to foster a deeper understanding of pharmacological innovations and therapeutic agents among its diverse readership.

Research in Pharmaceutical Sciences

Empowering Innovations in Pharmaceutical Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-5362Frequency: 6 issues/year

Research in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.

International Journal of Pharmaceutical Investigation

Fostering Dialogue on Cutting-Edge Pharmaceutical Practices
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

Pharmacy & Pharmacology-Farmatsiya i Farmakologiya

Elevating research standards in pharmacy and pharmacology.
Publisher: PYATIGORSKII MEDIKO-FARMATSEVTICHESKII INSTISSN: 2307-9266Frequency: 6 issues/year

Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is a distinguished journal published by the Pyatigorskii Mediko-Farmatsevticheskii Inst in the Russian Federation, dedicated to advancing research in the fields of pharmacy and pharmacology. Since its transition to an Open Access format in 2013, it has become an invaluable resource for researchers and professionals seeking to disseminate and access high-quality findings. With its ISSN 2307-9266 and E-ISSN 2413-2241, this journal covers a broad range of topics, providing a platform for the latest developments in pharmaceutical sciences. It is noteworthy that, as of 2023, Farmatsiya i Farmakologiya is categorized in various quartiles, with its Q2 ranking in Pharmacology (nursing) and Q3 in Pharmacy indicating its growing impact and relevance within its field. With the journal's commitment to fostering innovation and collaboration in pharmacy and pharmacology research, it serves as an essential hub for academics, practitioners, and students aiming to contribute to and stay informed about the dynamic landscape of this critical discipline.

Pharmacy

Connecting researchers and practitioners in the dynamic world of pharmaceuticals.
Publisher: MDPIISSN: Frequency: 6 issues/year

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.

Journal of Pharmacy and Bioallied Sciences

Unlocking Potential in Allied Health Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Indonesian Journal of Pharmacy

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: UNIV GADJAH MADA, FAC FARMASIISSN: 2338-9486Frequency: 4 issues/year

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.